• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON CARIBE LTD. BD AFFIRM¿ VPIII MICROBIAL IDENTIFICATION TEST; DNA PROBE, YEAST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON CARIBE LTD. BD AFFIRM¿ VPIII MICROBIAL IDENTIFICATION TEST; DNA PROBE, YEAST Back to Search Results
Catalog Number 446252
Medical Device Problem Code False Negative Result (1225)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/09/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event or Problem Description
It was reported that while using the bd affirm¿ vpiii microbial identification test, there were an unspecified number of false negative candida sp.Or gardnerella results on patient samples.Customer may send specimens for pap or next gen testing or perform a wet prep to confirm presence of yeast if candida result was negative.No patient impact was reported.
 
Additional Manufacturer Narrative
Investigation summary.Bd quality initiated an investigation on customer claim of false negative results on affirm catalog # 446252, batch # 3310323.Batch history review was performed on finished product and its components with satisfactory results.In process and qc testing were within specifications.Visual inspection was performed on retention samples with satisfactory results.Functional and specificity testing was also performed on retention samples with satisfactory results.This complaint was unable to be confirmed for affirm false negative results.Bd was unable to identify a root cause for indicated failure mode.Complaints received for this device and reported condition will continue to be tracked and trended.Our business team regularly reviews the collected data for identification of emerging trends.
 
Event or Problem Description
It was reported that while using the bd affirm¿ vpiii microbial identification test, there were an unspecified number of false negative candida sp.Or gardnerella results on patient samples.Customer may send specimens for pap or next gen testing or perform a wet prep to confirm presence of yeast if candida result was negative.No patient impact was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD AFFIRM¿ VPIII MICROBIAL IDENTIFICATION TEST
Common Device Name
DNA PROBE, YEAST
Manufacturer (Section D)
BECTON DICKINSON CARIBE LTD.
vicks drive
lot no. 6
cayey PR
Manufacturer (Section G)
BECTON DICKINSON CARIBE LTD.
vicks drive
lot no. 6
cayey PR
Manufacturer Contact
jo doyka
7 loveton circle
sparks, MD 21152
4103164000
MDR Report Key19202727
Report Number2647876-2024-00068
Device Sequence Number20859732
Product Code MLA
UDI-Device Identifier00382904462529
UDI-Public(01)00382904462529
Combination Product (Y/N)N
Initial Reporter StateIA
Initial Reporter CountryUS
PMA/510(K) Number
K931374
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 07/01/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date09/27/2024
Device Catalogue Number446252
Device Lot Number3310323
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/09/2024
Supplement Date Received by Manufacturer07/01/2024
Initial Report FDA Received Date04/29/2024
Supplement Report FDA Received Date07/11/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured11/06/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-